New Market Research Report: Kenya Pharmaceuticals & Healthcare Report Q1 2016
Our outlook for Kenya's pharmac eutical expenditure is positive and will be driven by expanding national health insurance coverage and improving public healthcare provision. While the Kenyan government is focused on improving its population's access to healthcare, drugmakers and medical device companies looking for a rapid return on investment will face challenges. Poor healthcare human resources and infrastructure will continue to limit the population ' s access to healthcare.
View full press release